These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 17159192)

  • 61. Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment.
    Rubino C; Shamsaldin A; Lê MG; Labbé M; Guinebretière JM; Chavaudra J; de Vathaire F
    Breast Cancer Res Treat; 2005 Feb; 89(3):277-88. PubMed ID: 15754127
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer.
    Kaufman EL; Jacobson JS; Hershman DL; Desai M; Neugut AI
    J Clin Oncol; 2008 Jan; 26(3):392-8. PubMed ID: 18202415
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mortality, leukemic risk, and cardiovascular toxicity of adjuvant anthracycline and taxane chemotherapy in breast cancer: a meta-analysis.
    Petrelli F; Borgonovo K; Cabiddu M; Lonati V; Barni S
    Breast Cancer Res Treat; 2012 Sep; 135(2):335-46. PubMed ID: 22689092
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Acute myeloid leukemia and myelodysplastic syndromes in older patients.
    Estey E
    J Clin Oncol; 2007 May; 25(14):1908-15. PubMed ID: 17488990
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
    Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
    Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Case-control study on the therapy of childhood cancer and the occurrence of second malignant neoplasms in Germany.
    Kaatsch P; Reinisch I; Spix C; Berthold F; Janka-Schaub G; Mergenthaler A; Michaelis J; Blettner M
    Cancer Causes Control; 2009 Aug; 20(6):965-80. PubMed ID: 19263232
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Is family history of breast cancer a marker of susceptibility to exposures in the incidence of de novo adult acute leukemia?
    Rauscher GH; Sandler DP; Poole C; Pankow J; Shore D; Bloomfield CD; Olshan AF
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):289-94. PubMed ID: 12692102
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Re: Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Warren JL; Brown ML
    J Natl Cancer Inst; 2007 Jul; 99(13):1050; author reply 1051-2. PubMed ID: 17596580
    [No Abstract]   [Full Text] [Related]  

  • 69. Mitoxantrone-associated acute myelogenous leukemia in a patient with high-risk adenocarcinoma of the prostate: a case report and brief review.
    Bowles DW; Flaig TW
    Cancer Invest; 2006; 24(5):517-20. PubMed ID: 16939961
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Therapy-related myeloid neoplasm in early breast cancer patients treated with adjuvant chemotherapy.
    Lee JW; Oh H; You JY; Lee ES; Lee JH; Song SE; Lee NK; Jung SP; An JS; Cho KR; Kim CY; Park KH
    Eur J Cancer; 2023 Sep; 191():112952. PubMed ID: 37473463
    [TBL] [Abstract][Full Text] [Related]  

  • 71. QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines.
    Arbel Y; Swartzon M; Justo D
    Anticancer Drugs; 2007 Apr; 18(4):493-8. PubMed ID: 17351403
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?
    Larson RA
    Best Pract Res Clin Haematol; 2007 Mar; 20(1):29-37. PubMed ID: 17336252
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer.
    Hooning MJ; Botma A; Aleman BM; Baaijens MH; Bartelink H; Klijn JG; Taylor CW; van Leeuwen FE
    J Natl Cancer Inst; 2007 Mar; 99(5):365-75. PubMed ID: 17341728
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Chemotherapy for acute myeloid leukemias with cytosine arabinoside, daunorubicin, etoposide, and mitoxantrone may cause permanent oligoasthenozoospermia or amenorrhea in middle-aged patients.
    Lemez P; Urbánek V
    Neoplasma; 2005; 52(5):398-401. PubMed ID: 16151584
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Alkaline comet assay study with breast cancer patients: evaluation of baseline and chemotherapy-induced DNA damage in non-target cells.
    Kopjar N; Milas I; Garaj-Vrhovac V; Gamulin M
    Clin Exp Med; 2006 Dec; 6(4):177-90. PubMed ID: 17191110
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.
    van den Belt-Dusebout AW; Aleman BM; Besseling G; de Bruin ML; Hauptmann M; van 't Veer MB; de Wit R; Ribot JG; Noordijk EM; Kerst JM; Gietema JA; van Leeuwen FE
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1420-9. PubMed ID: 19931732
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Results of a multicenter phase II trial for older patients with c-Kit-positive acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS) using low-dose Ara-C and Imatinib.
    Heidel F; Cortes J; Rücker FG; Aulitzky W; Letvak L; Kindler T; Huber C; Döhner H; Kantarjian H; Fischer T
    Cancer; 2007 Mar; 109(5):907-14. PubMed ID: 17285599
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: a population-based study.
    Chaplain G; Milan C; Sgro C; Carli PM; Bonithon-Kopp C
    J Clin Oncol; 2000 Aug; 18(15):2836-42. PubMed ID: 10920131
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Re: Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Clavarezza M; Del Mastro L; Pronzato P; Bruzzi P; Venturini M
    J Natl Cancer Inst; 2007 Jul; 99(13):1050-1; author reply 1051-2. PubMed ID: 17596581
    [No Abstract]   [Full Text] [Related]  

  • 80. Incidence of secondary myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in patients with ovarian or breast cancer in a real-world setting in the United States.
    Shenolikar R; Durden E; Meyer N; Lenhart G; Moore K
    Gynecol Oncol; 2018 Nov; 151(2):190-195. PubMed ID: 30268525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.